136 related articles for article (PubMed ID: 28121349)
1. BPTF biomarker correlates with poor survival in human NSCLC.
Gong YC; Liu DC; Li XP; Dai SP
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):102-107. PubMed ID: 28121349
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
[TBL] [Abstract][Full Text] [Related]
3. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA Loc344887 is a potential prognostic biomarker in non-small cell lung cancer.
Wu B; Zhang XJ; Li XG; Jiang LS; He F
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3808-3812. PubMed ID: 28975987
[TBL] [Abstract][Full Text] [Related]
5. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
6. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.
Grinberg-Rashi H; Ofek E; Perelman M; Skarda J; Yaron P; Hajdúch M; Jacob-Hirsch J; Amariglio N; Krupsky M; Simansky DA; Ram Z; Pfeffer R; Galernter I; Steinberg DM; Ben-Dov I; Rechavi G; Izraeli S
Clin Cancer Res; 2009 Mar; 15(5):1755-61. PubMed ID: 19190132
[TBL] [Abstract][Full Text] [Related]
7. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer.
Xu J; Wang Q; Leung ELH; Li Y; Fan X; Wu Q; Yao X; Liu L
Front Med; 2020 Feb; 14(1):60-67. PubMed ID: 31104301
[TBL] [Abstract][Full Text] [Related]
8. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
[No Abstract] [Full Text] [Related]
9. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
11. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
12. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection.
Jiang W; Pang XG; Wang Q; Shen YX; Chen XK; Xi JJ
Clin Lung Cancer; 2012 Jul; 13(4):280-7. PubMed ID: 22178381
[TBL] [Abstract][Full Text] [Related]
14. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
[TBL] [Abstract][Full Text] [Related]
16. BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas.
Dai M; Lu JJ; Guo W; Yu W; Wang Q; Tang R; Tang Z; Xiao Y; Li Z; Sun W; Sun X; Qin Y; Huang W; Deng WG; Wu T
Oncotarget; 2015 Oct; 6(32):33878-92. PubMed ID: 26418899
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-3666 inhibits lung cancer cell proliferation, migration, and invasiveness by targeting BPTF.
Pan L; Tang Z; Pan L; Tang R
Biochem Cell Biol; 2019 Aug; 97(4):415-422. PubMed ID: 30481052
[TBL] [Abstract][Full Text] [Related]
18. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.
Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S
Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
